Ginkgo Bioworks’ Datapoints unit unveiled the Virtual Cell Pharmacology Initiative (VCPI), an open‑source effort to standardize virtual cell modeling by generating high‑quality pharmacology data on a reference engineered cell line (V‑Ref293). Ginkgo said VCPI will produce data on at least 100,000 compounds and over 12 billion data points to train predictive virtual cell models. John Androsavich, GM of Ginkgo Datapoints, called the initiative a bid to marry quantity with reproducible, high‑signal wet‑lab measurements so AI models can better predict drug effects. The program offers RNA profiling to contributors free of charge and plans to distribute master cell bank vials in 2026, aiming to set shared standards for virtual cell research.